Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program

被引：8
|
作者：
Feit, Noah Z. [1 ]
Goldman, Debra A. [2 ]
Smith, Evan [3 ]
Deighan, Jenny [4 ]
Iasonos, Alexia [1 ,2 ]
Zivanovic, Oliver [3 ]
Hyman, David M. [1 ,5 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
[4] Mem Sloan Kettering Ctr, Human Res Protect Program, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Early Drug Dev Serv, 1275 York Ave, New York, NY 10128 USA
来源：
JAMA ONCOLOGY | 2019年 / 5卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1001/jamaoncol.2018.7002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：570 / 572
页数：3
相关论文
共 50 条
  • [1] US Food and Drug Administration Efforts to Facilitate the Use of Expanded Access Programs
    Kim, Tamy
    Lurie, Peter
    Pazdur, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (33) : 3979 - +
  • [2] Single-patient expanded access: A primer for pharmacists
    Smith, Andrew J. F.
    Redic, Kimberly A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (23) : 2118 - 2127
  • [3] Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs
    Puthumana, Jeremy
    Miller, Jennifer E.
    Kim, Jeanie
    Ross, Joseph S.
    [J]. JAMA NETWORK OPEN, 2018, 1 (02) : e180283
  • [4] Single-patient use disposable syringes
    [J]. British Dental Journal, 2007, 203 (11) : 663 - 663
  • [5] Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First US Experience from an Expanded Access Program
    Sartor, Oliver
    Vogelzang, Nicholas J.
    Sweeney, Christopher
    Fernandez, Daniel C.
    Almeida, Fabio
    Iagaru, Andrei
    Brown, Alan, Jr.
    Smith, Matthew R.
    Agrawal, Manish
    Dicker, Adam P.
    Garcia, Jorge A.
    Lutzky, Jose
    Wong, Yu-Ning
    Petrenciuc, Oana
    Gratt, Jeremy
    Shore, Neal D.
    Morris, Michael J.
    [J]. ONCOLOGIST, 2018, 23 (02): : 193 - 202
  • [6] Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications
    Desai, Ravi J.
    Good, Meghan M.
    San-Juan-Rodriguez, Alvaro
    Henriksen, Andrew
    Cunningham, Francesca
    Hernandez, Inmaculada
    Good, Chester B.
    [J]. JAMA NETWORK OPEN, 2019, 2 (09)
  • [7] Food and Drug Administration analysis of 1332 single patient and emergency use expanded access (compassionate use) requests for patients with cancer over a duration of three years (2012-2014)
    Lemery, Steven J.
    Mailankody, Sham
    Kazandjian, Dickran
    Smit, Marie-Anne Damiette
    Blumenthal, Gideon Michael
    Kim, Tamy
    Keegan, Patricia
    Pazdur, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Food and Drug Administration Responds to Pressure for Expanded Drug Access
    Brower, Vicki
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (06)
  • [9] Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
    Feldman, Daniel
    Avorn, Jerry
    Kesselheim, Aaron S.
    [J]. JAMA NETWORK OPEN, 2022, 5 (04) : E227958
  • [10] Efficacy and Safety Results of the Afatinib Expanded Access Program
    Edward S. Kim
    Balazs Halmos
    Ingrid F. Kohut
    Taral Patel
    Regan D. Rostorfer
    Alexander I. Spira
    Agnieszka Cseh
    John McKay
    Gudrun Wallenstein
    Kathryn F. Mileham
    [J]. Oncology and Therapy, 2017, 5 (1) : 103 - 110
12345